Globela Laboratories Private Limited — Cefuroxime Exporter Profile
Indian Pharmaceutical Exporter · #15 for Cefuroxime · $1.1M export value · DGFT Verified
Globela Laboratories Private Limited is the #15 Indian exporter of Cefuroxime with $1.1M in export value and 26 verified shipments. Globela Laboratories Private Limited holds a 0.9% market share in Cefuroxime exports across 3 countries.
Globela Laboratories Private Limited — Cefuroxime Export Profile: Buyers & Destinations
Where Does Globela Laboratories Private Limited Export Cefuroxime?
| Country | Value | Shipments | Share |
|---|---|---|---|
| PHILIPPINES | $634.2K | 21 | 88.3% |
| PERU | $72.9K | 4 | 10.2% |
| KENYA | $11.0K | 1 | 1.5% |
Globela Laboratories Private Limited exports Cefuroxime to 3 countries. The largest destination is PHILIPPINES accounting for 88.3% of Globela Laboratories Private Limited's Cefuroxime shipments, followed by PERU (10.2%) and KENYA (1.5%). These destinations reflect Globela Laboratories Private Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Cefuroxime from Globela Laboratories Private Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| AMB HK ENTERPRISES INC | PHILIPPINES | $350.0K | 10 |
| AMB HK ENTERPRISES INC. | PHILIPPINES | $284.1K | 11 |
| DROGUERIA LIPHARMA SAC | PERU | $72.9K | 4 |
| PHARMAKEN | KENYA | $11.0K | 1 |
Globela Laboratories Private Limited supplies Cefuroxime to 4 buyers globally. The largest buyer is AMB HK ENTERPRISES INC (PHILIPPINES), followed by AMB HK ENTERPRISES INC. (PHILIPPINES) and DROGUERIA LIPHARMA SAC (PERU). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Cefuroxime Export Value and How Much Does Globela Laboratories Private Limited Contribute?
India exported $82.9M worth of Cefuroxime through 6,961 shipments from 440 suppliers to 150 countries, serving 1,458 buyers globally. Globela Laboratories Private Limited contributes $1.1M to this total, accounting for 0.9% of India's Cefuroxime exports. Globela Laboratories Private Limited ships Cefuroxime to 3 countries through 4 buyers.
What Is the Average Shipment Value for Globela Laboratories Private Limited's Cefuroxime Exports?
Globela Laboratories Private Limited's average Cefuroxime shipment value is $42.6K per consignment, based on 26 shipments totaling $1.1M. The largest destination is PHILIPPINES (88.3% of Globela Laboratories Private Limited's Cefuroxime exports).
How Does Globela Laboratories Private Limited Compare to Other Indian Cefuroxime Exporters?
Globela Laboratories Private Limited ranks #15 among 440 Indian Cefuroxime exporters with a 0.9% market share. The top 3 exporters are AUROBINDO PHARMA LTD ($18.5M), SUN PHARMACEUTICAL INDUSTRIES LIMITED ($16.8M), ALKEM LABORATORIES LIMITED ($11.6M). Globela Laboratories Private Limited processed 26 shipments to 3 destination countries.
What Cefuroxime Formulations Does Globela Laboratories Private Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| PHILCEF 250 PACK 60ML CEFUROXIME AXETIL 250 MG SUSP BATCH NO GLD23014 TO 018 AND GLD23020 MFG DT 03 2023 EXP DT 0 | $100.0K | 2 |
| EROXIME-500 (CEFUROXIME AXETIL 500 MG TA | $100.0K | 2 |
| EROXIME 500 CEFUROXIME AXETIL 500 MG TABLET BATCH NO GLT23012 GLT23013 MFG DT 02 2023 EXP DT 01 2026 | $83.7K | 2 |
| PHILCEF 125 PACK 60ML CEFUROXIME AXETIL 125 MG SUSP BATCH NO GLD23007 GLD23009 GLD23010 GLD23013 MFG DT 03 2023 EXP | $68.4K | 2 |
| EROXIME - 500 (PACK 1X10'S)(CEFUROXIME AXETIL 500 MG TABLET)(BATCH NO GLT23135 MFG DT 09/2023 EXP DT 08/2026 BATCH NO GNOS | $65.1K | 3 |
| PHILCEF- 125 (PACK 60ML)(CEFUROXIME AXET | $50.0K | 1 |
| PHILCEF- 250 (PACK 60ML)(CEFUROXIME AXET | $50.0K | 1 |
| EROXIME 500 CEFUROXIME AS AXETIL 500M | $50.0K | 1 |
| QUADCEF 500 CEFUROXIME AXETIL 500 MG TABLET BATCH NO GLT23011 MFG DT 02 2023 EXP DT 01 2026 | $34.7K | 2 |
| CEFSTALIP - 500 (Cefuroxime Axetil. USP | $24.9K | 2 |
Globela Laboratories Private Limited exports 18 distinct Cefuroxime formulations including tablets, capsules, syrups, and combination drugs. The top formulation is PHILCEF 250 PACK 60ML CEFUROXIME AXETIL 250 MG SUSP BATCH NO with 2 shipments worth $100.0K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.
How Does Globela Laboratories Private Limited Compare to Nearest Cefuroxime Exporters?
Exporters ranked immediately above and below #15 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 9 | STERLING LAB, | $1.4M | 29 | 2 | $50.0K |
| 13 | ESMERO RESEARCH PRIVATE LIMITED | $1.3M | 33 | 1 | $38.4K |
| 15 | GLOBELA LABORATORIES PRIVATE LIMITED ★ | $1.1M | 26 | 3 | $42.6K |
| 14 | MEDICO REMEDIES LIMITED | $1.1M | 21 | 3 | $50.0K |
Globela Laboratories Private Limited ranks #15 among 440 Indian Cefuroxime exporters. Average shipment value of $42.6K compared to the market average of $188.4K. The closest competitors by value are STERLING LAB, and ESMERO RESEARCH PRIVATE LIMITED.
Which Indian Ports Ship Cefuroxime Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 707 | 10.2% |
| SAHAR AIR | 670 | 9.6% |
| NHAVA SHEVA SEA (INNSA1) | 661 | 9.5% |
| HYDERABAD ICD | 316 | 4.5% |
| DELHI AIR | 312 | 4.5% |
| DELHI AIR CARGO ACC (INDEL4) | 300 | 4.3% |
| JNPT/ NHAVA SHEVA SEA | 281 | 4.0% |
| HYDERABAD ICD (INSNF6) | 278 | 4.0% |
Market Intelligence
Latest developments and market context
Detailed market intelligence for Cefuroxime — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Cefuroxime shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Globela Laboratories Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 26 individual customs records matching Globela Laboratories Private Limited exporting Cefuroxime, covering 18 formulations to 3 countries via 4 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 150+ countries, 1,458+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Cefuroxime Export Data from Globela Laboratories Private Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Globela Laboratories Private Limited's Cefuroxime exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Globela Laboratories Private Limited
Company Profile
0 products · $0 total trade · 0 categories
Cefuroxime Stats
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Globela Laboratories Private Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Cefuroxime. For current shipment-level data, contact TransData Nexus.